Overview of Dr. Guttmann
I am a Radiation Oncologist at Memorial Sloan Kettering Cancer Center seeing patients at our Westchester and Bergen County locations. I received my medical degree from Perelman School of Medicine at the University of Pennsylvania and completed by Residency in Radiation Oncology at the Hospital of the University of Pennsylvania in 2018. I am in experienced in treatment of prostate cancer, breast cancer, lung cancer, gastrointestinal cancers, and metastatic disease including brain and spinal cord tumors.
Office
500 Westchester Avenue
West Harrison, NY 10604
Education & Training
- University of Pennsylvania Health SystemResidency, Radiation Oncology, 2013 - 2018
- University of PennsylvaniaM.T.R., Translational Research, 2011 - 2013
- Perelman School of Medicine at the University of PennsylvaniaClass of 2013
- Brown UniversitySc.B., Biochemistry, Phi Beta Kappa, Magna Cum Laude, 2003 - 2007
Certifications & Licensure
- FL State Medical License 2023 - Present
- NY State Medical License 2018 - 2026
- CT State Medical License 2023 - 2025
- NJ State Medical License 2018 - 2025
- NC State Medical License 2021 - 2022
- PA State Medical License 2013 - 2018
- American Board of Radiology Radiation Oncology
- AHAACLS
Awards, Honors, & Recognition
- Alpha Omega Alpha University of Pennsylvania, 2013
- Fulbright Fellowship Weizmann Institute of Science, Rehovot, Israel, 2013
- Graduation with Honors Thesis in Biochemistry Brown University, 2007
- Join now to see all
Clinical Trials
- A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer Start of enrollment: 2023 May 17
Roles: Contact
Publications & Presentations
PubMed
- 40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.Assaf Moore, Zhigang Zhang, Teng Fei, Lei Zhang, Laura Accomando
Neurosurgery. 2024-08-01 - Implementation Strategies to Promote Short-Course Radiation for Bone Metastases.Erin F Gillespie, Patricia Mae G Santos, Michael Curry, Talya Salz, Nirjhar Chakraborty
JAMA Network Open. 2024-05-01 - 23 citationsStandard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consoli...Chiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, Juber Patel, Annemarie F Shepherd
Lancet. 2024-01-13
Abstracts/Posters
- Radiation Dermatitis and Modality Predict Wound Complications in Patients with Soft Tissue Sarcoma.LeBrun DG, Guttmann DM, Levin WP, Kovach SJ, Weber KL, American Academy of Orthopedic Surgeons Annual Meeting, 1/1/2017
- Head and Neck Cancer Survival Outcome Prediction Based on NRG Oncology RTOG 0522 with Random Forests and Random Survival Forests.Huang M, Cheng C, Geng H, Zhong H, Wang J, Lin A, Guttmann D, Soest J, Dekker A, Bilker W, Zhang Z, Rosenthal D, Axelrod R, Galvin J, Frank S, Thorstad W, Huth B, Hsu ..., American Association of Physicists in Medicine Annual Meeting, 1/1/2017
- Evaluation of a Knowledge-Based Atlas for Automated Cardiac Structures Quality Assurance for NCTN Clinical Trial NRG Oncology RTOG 0617 and 1308.Hunag M, Guttmann D, Yu J, Cheng C, Geng H, Zhong H, Gore E, Bradley J, Liao Z, Forster K, Gillin M, Mohan R, Xiao Y, American Association of Physicists in Medicine Annual Meeting, 1/1/2017
- Join now to see all
Other
- Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Central Nervous System. Proton therapy education moduleGuttmann DM, OncoLink.org
https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
1/8/2015 - Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Connective Tissues and Bone. Proton therapy education moduleGuttmann DM, OncoLink.org
https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
1/8/2015 - Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Head and Neck. Proton therapy education moduleGuttmann DM, OncoLink.org
https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
1/8/2015 - Join now to see all
Press Mentions
- FDA Approves Zenocutuzumab for Pancreatic and Lung Cancers with NRG1 FusionsDecember 5th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: